NYSE · Pharmaceuticals
Eli Lilly and Company (LLY) Stock Price & Forecast
$902.50-8.30 (-0.91%)Illustrative delayed price
Key data
- Market cap
- $857bn
- P/E ratio
- 58.4
- Dividend yield
- 0.66%
- Employees
- 47,000
- Headquarters
- Indianapolis, Indiana
- Founded
- 1876
- Listing
- NYSE · United States
- Currency
- $
About Eli Lilly and Company
Eli Lilly's incretin franchise has made it the largest healthcare company by market value and the sector's main driver of index performance.
Analyst ratings & price target
Consensus across 29 covering analysts.
- Consensus
- Buy
- Average target
- $1020.00
- High target
- $1250.00
- Low target
- $700.00
| Buy | 23 |
|---|---|
| Hold | 5 |
| Sell | 1 |
Earnings
Next report and the most recent quarter on record.
- Next report
- 2026-11-05
- Period
- Q3 2026
- Consensus EPS
- $7.14
- Last reported
- 2026-08-06
- Last EPS
- $6.82
- Last revenue
- $17.9bn
- EPS surprise
- +5.5%
Related stocks
Related coverage
Free newsletter
Market Daily
One email before the US open: the overnight moves, the day's earnings, and the one number worth watching. No tips, no hype.
Prices, valuation multiples, consensus estimates and target prices on this page are illustrative and delayed. Nothing here is investment advice or a recommendation to buy or sell any security. See our editorial standards.